Biomarkers in Clinical Trials, 20th & 21st September 2010, Central London
european cancer organisation swissbridge
ISSN: 1754-6605

Details

Download

Share

Contribute

Discuss

Explore

Role of traditional and new biomarkers in breast carcinogenesis

D. Macis, M. Cazzaniga, A. De Censi, B. Bonanni

During the last decades several biomarkers have been investigated for their possible role as predictors of breast cancer risk, development, prognosis and treatment efficacy.
The discovery of biomarkers strongly associated with breast carcinogenesis has an enormous potential especially for the selection of subjects at high-risk for developing breast cancer who may benefit from chemopreventive treatments.
Although the number of analyzed biomarkers continue to increase, an unique biomarker for breast cancer risk prediction has not been identified and it is more likely that a panel of biomarkers should be taken into account. Anyhow, further studies are needed to validate breast cancer biomarkers evaluation for individual risk assessment.
This review summarizes main biomarkers that have found to have significant roles at different stages of breast carcinogenesis with updates from the more recent literature.

Volume: 3  Article Number: 157  DOI: 10.3332/ecancer.2009.157  Received: 24/09/2009  Published: 29/10/2009

To view this article in its entirety you must first login or register.